Not All Shockwave is Created Equal.
Choose FDA-Approved and FDA-Cleared, evidence-based Radial Pressure Wave and Focused Shockwave devices from CuraMedix, the #1 trusted STORZ Medical U.S. Distribution Partner.
Trusted by healthcare providers and professional sports organizations dedicated to achieving consistent, evidence-based results.
Why Leading
Healthcare Providers Choose CuraMedix
- The CuraMedix portfolio of Shockwave and EMTT devices, powered by STORZ Medical, represents the gold standard in regenerative technology.
- CuraMedix is proud to represent STORZ Medical as the #1 full-service U.S. distribution partner, supporting the complete suite of Radial Pressure Wave and Focused Shockwave devices.
- Partnering with CuraMedix means investing in authentic STORZ Medical technologies, backed by comprehensive training, service, and ongoing clinical support, empowering you to deliver next-level outcomes in patient care.
Clinicians Leading In Outcomes Are Leading With Shockwave.
If you're treating patients who are suffering from acute or chronic musculoskeletal pain and don't have Shockwave in your armentarium, you are missing out on a technology that has been proven to accelerate healing, and risking that they will seek care elsewhere.
Write Off 100% of Your Investment This Year
The Section 179 tax deduction allows healthcare practices to deduct the full purchase price of qualifying equipment purchased or financed during the tax year. This means you can write off the entire cost of your CuraMedix Shockwave device immediately—rather than depreciating it over several years.
Immediate Deduction
Deduct up to $2.5 million in equipment purchases for 2025, including your investment in new Shockwave devices.
Accelerated Cash Flow
Convert your tax savings into immediate working capital. A $50,000 device could save you $17,500 in taxes this year.
Qualifying Purchases
All CuraMedix Shockwave devices qualify as medical equipment under the Section 179 guidelines.
Your Potential Tax Savings
*Consult your tax advisor for specific calculations based on your practice's situation.
⚠️ Section 179 deadline: December 31, 2025
Invest in Proven Regenerative Technology, Take Advantage of Section 179, and Maximize Your Year-End ROI.
Ready to learn more about Shockwave?